Company Overview and News

 
LUK / Leucadia National Corp. null

2018-04-13 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) PROXY STATEMENT PURSUANT TO SECTION 1
Upvote Downvote

 
LUK / Leucadia National Corp. null

2018-04-13 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) PROXY STATEMENT PURSUANT TO SECTION 1
Upvote Downvote

 
Leucadia National's Game-Changing Strategy

2018-04-10 seekingalpha
The management team at Leucadia announced a major shift in their business model on April 9th.
Upvote Downvote

 
General Electric & Mass Energy Group to Develop Wind Project

2018-04-10 zacks
General Electric Company’s (GE - Free Report) Renewable Energy segment recently signed a contract with Mass Energy Group Holding — a subsidiary of Mass Global — for the development of 100 MW Mass Wind project in Jordan.
Upvote Downvote

 
Honeywell Unveils Satellite Communications System, Aspire 40

2018-04-10 zacks
Honeywell International Inc. (HON - Free Report) recently announced the availability of Aspire 40, its newest satellite communications system. Apart from offering critical cockpit safety services to pilots, the system provides passengers and aircraft flight crews with an access to global voice and data connectivity. Also, it ensures safer and more efficient flights for business jets, commercial and military aircraft by offering a simultaneous connectivity to both the cockpit and the cabin.
Upvote Downvote

 
Hovnanian's Weird CDS Trade Gets Weirder - Bloomberg

2018-04-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Leucadia Stock Soars on Divesture, to Rename Itself Jefferies

2018-04-10 zacks
Shares of Leucadia National Corporation (LUK - Free Report) rose 11.6% on Apr 9, (its biggest jump since 2009) after the diversified conglomerate disclosed the divesture of its auto dealer group and a portion of its stake in its beef cattle business for roughly $1.33 billion. The company is reorganising operations to focus on investment banking and advisory services, as it plans to capitalize on the growth opportunities in the finance field.
Upvote Downvote

 
LUK / Leucadia National Corp. 8-K (Current Report)

2018-04-10 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K
Upvote Downvote

 
Wall Street rises but pares gains late after report of FBI raid

2018-04-10 thehindubusinessline
The Dow Jones Industrial Average rose 46.34 points, or 0.19 per cent, to 23,979.10, the S&P 500 gained 8.69 points, or 0.33 per cent, to 2,613.16 and the Nasdaq Composite added 35.23 points, or 0.51 per cent, to 6,950.34.
Upvote Downvote

 
Wall Street rises but pares gains late after report of FBI raid

2018-04-09 themalaymailonline
Traders work on the floor of the New York Stock Exchange shortly after the opening bell February 22, 2018. — Reuters picNEW YORK, April 10 — Wall Street's major indexes rose yesterday as a softer stance by US policymakers on China tariffs powered a rebound from last week's selloff, but stocks pared much of their gains late in the session after a report that the Federal Bureau of Investigation raided the office of President Donald Trump's lawyer.
Upvote Downvote

 
Wall Street rises but pares gains late after report of FBI raid

2018-04-09 channelnewsasia
U.S. stock index futures rose on Monday ahead of the start of earnings season, pointing to an easing of last week's selloff after officials of the Trump administration stressed the trade dispute with China could be resolved through talks.
Upvote Downvote

 
Monday’s Biggest Winners and Losers in the S&P 500

2018-04-09 247wallst
Monday was another positive day for the broad U.S. markets. This was yet another push towards recovery and back to even for the three major indices. Crude oil also made a handy recovery as well. The S&P 500 sectors were mostly positive. The most positive sectors were health care, technology, and financials discretionary up 1.0%, 0.8%, and 0.6%, respectively. The worst performing sector was industrials which was down 0.
Upvote Downvote

 
Wall Street indexes rise over 1 percent as trade worries ease

2018-04-09 channelnewsasia
U.S. stock index futures rose on Monday ahead of the start of earnings season, pointing to an easing of last week's selloff after officials of the Trump administration stressed the trade dispute with China could be resolved through talks.
Upvote Downvote

 
Wall Street higher as tech stocks gain, trade war worries ebb

2018-04-09 channelnewsasia
U.S. stock index futures rose on Monday ahead of the start of earnings season, pointing to an easing of last week's selloff after officials of the Trump administration stressed the trade dispute with China could be resolved through talks.
Upvote Downvote

 
Wall Street higher as US-China trade war worries ebb

2018-04-09 themalaymailonline
A Wall Street sign is pictured outside the New York Stock Exchange in New York, October 28, 2013. — Reuters picNEW YORK, April 9 — Wall Street rebounded from last week’s trade tariff driven selloff to open higher today, taking comfort in comments from the Trump administration officials who stressed the trade dispute with China could be resolved through talks.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 527288104